达安基因：未来公司将全面进入IVD全领域，聚焦于诊断技术和产品的临床、公共卫生、检验检疫等全场景应用

七印授权

4JSCN7AATVB0ENPDJ4ODPMCGDVGI8U7LRE8SB34UJHLHRXN5VE

2022-05-26 10:51:56

article

E77057B8EA9E57E888E041D4EF2852305E597086C6C2644575EB616491802002

zh-CN

9A92025DB8A17B535920403CBE7AD7C38D960666

12366149

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

7ab16807d6f7df05e9e06930ce1c69596ffed03a0bd950dcbde185d7aea778a46c0000d7500fc0dbd9e4874b0e73e38e53062094ea43381ab838a74e3bc329221c

{"parameters":{"adaptation":"n","price":"100000"},"type":"cm"}

yuanben_628f5bcc7cc3b0.54622034

原本认证

https://www.yuanben.io/article/2d4409b2-bb3c-4541-b317-c7d058d86c16

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}